Profound Medical Corp Stock Toronto S.E.
Stocks
PRN
CA74319B1067
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
||
| - CAD | - |
|
| 05-15 | Profound Medical Corp. Approves Board Election | CI |
| 05-15 | Telix to Collaborate With EDAP, Profound Medical to Explore PSMA-PET Imaging in Prostate Cancer Therapies | MT |
| Market Cap | 354M 249M 218M 200M 187M 23.75B 360M 2.41B 935M 11.67B 936M 916M 40.23B | P/E 2026 * |
-8.41x | P/E 2027 * | -9.45x |
|---|---|---|---|---|---|
| Enterprise Value | 354M 249M 218M 200M 187M 23.75B 360M 2.41B 935M 11.67B 936M 916M 40.23B | EV / Sales 2026 * |
9.91x | EV / Sales 2027 * | 5.84x |
| Free-Float |
95.93% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Profound Medical Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Arun Menawat
CEO | Chief Executive Officer | 71 | 2016-08-14 |
Mathieu Burtnyk
PSD | President | 44 | 2024-11-06 |
Rashed Dewan
DFI | Director of Finance/CFO | 58 | 2022-03-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Arun Menawat
CHM | Chairman | 71 | - |
Brian Ellacott
BRD | Director/Board Member | 68 | 2018-06-13 |
Arthur Rosenthal
BRD | Director/Board Member | 79 | 2018-06-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.97% | +2.03% | +21.92% | +0.55% | 195B | |
| +5.87% | +5.27% | -21.76% | +27.59% | 151B | |
| +2.17% | +0.89% | -2.59% | -16.62% | 140B | |
| +4.83% | +2.06% | -56.73% | -15.23% | 67.09B | |
| +2.59% | +3.95% | +22.89% | +3.75% | 54.34B | |
| +0.13% | +2.97% | -24.74% | -28.99% | 44.63B | |
| +0.31% | +1.30% | +8.30% | +42.29% | 37.24B | |
| -2.02% | -3.91% | +7.67% | +9.36% | 36.91B | |
| +4.24% | +4.66% | -18.42% | -3.15% | 30.24B | |
| Average | +0.35% | +2.74% | -7.05% | +2.17% | 83.99B | |
| Weighted average by Cap. | -0.29% | +3.44% | -3.99% | +2.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 35.76M 25.18M 22.01M 20.23M 18.85M 2.4B 36.3M 243M 94.4M 1.18B 94.5M 92.47M 4.06B | 60.68M 42.72M 37.35M 34.32M 31.99M 4.07B 61.6M 412M 160M 2B 160M 157M 6.89B |
| Net income | -43.31M -30.49M -26.66M -24.5M -22.83M -2.9B -43.97M -294M -114M -1.43B -114M -112M -4.92B | -40.7M -28.66M -25.05M -23.02M -21.46M -2.73B -41.32M -276M -107M -1.34B -108M -105M -4.62B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- PRN Stock
- PRN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
